The ACRB is proud to coordinate an exciting new study created to improve the identification of breast cancer. This goal of study is to use a single blood sample to detect and diagnose breast cancer. The program, called Syantra, is led by a University of Calgary researcher. The ‘Identification of Breast Cancer from a Blood Sample (IDBC)’ study is looking to recruit 1,200 women. Eligible women will have been referred for a biopsy. In addition, women can participate if they have had a normal mammogram or negative physical breast exam within the last 9 months.
If you would like participate, you will be asked to:
Discuss the project with our IDBC Study Coordinator. If you agree to participate, please complete and sign a consent form. This will allow the IDBC study to store and use your de-identified blood sample and health information.
Provide a voluntary blood sample (1-3 teaspoons). This can be done at the same time as other blood work, but must be completed before treatment (such as a biopsy) is performed.
Complete a short questionnaire to provide additional information about you and your health history.
If you have any questions or would like more information, please contact our IDBC Study Coordinator at 403.521.3604 or email@example.com. Also read through the IDBC Consent Form, IDBC Questionnaire or IDBC Brochure.
Thank you for considering this important study!!
Read more about the IDBC study here: https://myleapmagazine.ca/2018/07/26/new-blood-test-improve-accuracy-breast-cancer-screening/.